Contact your healthcare provider: Seek medical guidance if you have persistent vomiting or diarrhea, cannot keep fluids down, feel unusually weak or dizzy, or have concerns about dehydration or medication side effects
Wamsteker, K., Emanuel, M
FDA labeling for GLP-1 medications approved for chronic weight management, along with major clinical guidelines, generally describes candidates as adults with a BMI of 30 or higher, or a BMI of 27 or higher when accompanied by at least one weight-related health condition such as high blood pressure, type 2 diabetes, or abnormal cholesterol levels
It can neutralize free radicals, reduce oxidative stress, and act as a detoxifying agent
For all GLP-1 users, including retatrutide, creating a surgery timeline should account for individual weight loss trends and goals and discussions with providers
The second role is to physically bind itself to toxins that our bodies are exposed to and remove them from the body